OSMR beta hFc Chimera, Human
OSMR Beta HFc Chimera, Human

Immobilized OSMR beta hFc Chimera, Human, hFc Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-OSMR Antibody, hFc Tag with the EC50 of 10.2ng/ml determined by ELISA.

OSMR Beta HFc Chimera, Human

The purity of OSMR beta hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

OSMR Beta HFc Chimera, Human

OSMR beta hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

OSMR beta hFc Chimera, Human

OSMR is targeted to the mitochondrial matrix via the presequence translocase-associated motor complex components, mtHSP70 and TIM44. OSMR interacts with NADH ubiquinone oxidoreductase 1/2 (NDUFS1/2) of complex I and promotes mitochondrial respiration. Deletion of OSMR impairs spare respiratory capacity, increases reactive oxygen species, and sensitizes BTSCs to IR-induced cell death.
Z05719
¥69,021.00

Ask us a question
Product Introduction
Species Human
Protein Construction
OSMR beta (Glu28-Met740)_x000D_
Accession # Q99650-1		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1 EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 107.06 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 120-140 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • OSMR Beta HFc Chimera, Human
    • OSMR Beta HFc Chimera, Human

    Immobilized OSMR beta hFc Chimera, Human, hFc Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-OSMR Antibody, hFc Tag with the EC50 of 10.2ng/ml determined by ELISA.

  • OSMR Beta HFc Chimera, Human
    • OSMR Beta HFc Chimera, Human

    The purity of OSMR beta hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

  • OSMR Beta HFc Chimera, Human
    • OSMR Beta HFc Chimera, Human

    OSMR beta hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background OSMR is targeted to the mitochondrial matrix via the presequence translocase-associated motor complex components, mtHSP70 and TIM44. OSMR interacts with NADH ubiquinone oxidoreductase 1/2 (NDUFS1/2) of complex I and promotes mitochondrial respiration. Deletion of OSMR impairs spare respiratory capacity, increases reactive oxygen species, and sensitizes BTSCs to IR-induced cell death.
Synonyms IL-31R subunit beta; IL-31R-beta; IL-31RB; OSMR beta; OSMR; OSMRB; OSMRBMGC150626; PLCA1 ;IL-31R subunit β; IL-31R-β; OSMR β

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.